期刊文献+

关于乙型肝炎病毒预存耐药变异的认识 被引量:5

原文传递
导出
摘要 核苷(酸)类似物长期抗乙型肝炎病毒(hepatitis B virus,HBV)治疗面临的最重要问题之一是HBV的耐药性问题[1].目前口服的核苷(酸)类似物,包括拉米夫定、阿德福韦、恩替卡韦和替比夫定,治疗过程中均可出现耐药性.特别是近年来发现慢性乙型肝炎患者在核苷(酸)类似物治疗前即存在耐药位点突变,即预存耐药变异(pre-existing antiviral resistance mutation),引起了临床医师的高度关注. 一、HBV预存耐药变异的基础.
出处 《中华临床医师杂志(电子版)》 CAS 2012年第20期19-20,共2页 Chinese Journal of Clinicians(Electronic Edition)
基金 南京市医学科技发展项目青年科技人才启动项目(QYK09154) 南京市科技发展计划项目(201108014) 江苏省自然科学基金(BK2011100)
  • 相关文献

参考文献15

  • 1刘晓峰.慢性乙型肝炎抗病毒耐药的防治策略[J].中华临床医师杂志(电子版),2008,2(10):6-9. 被引量:5
  • 2Nowak MA,Bonhoeffer S,Hill AM. Viral dynamics in hepatitis B virus infection[J].Proceedings of the National Academy of Sciences(USA),1996.4398-4402.
  • 3Simmonds P. The origin and evolution of hepatitis viruses in humans[J].Journal of General Virology,2001.693-712.
  • 4Zoulim F. Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection[J].Antiviral Rre,2004.1-15.
  • 5Chang MH. Hepatitis B virus mutation in children[J].Indian Journal of Pediatrics,2006.803-807.
  • 6Lee SH,Kim HS,Byun IS. Pre-existing YMDD mutants in treatment-naive patients with chronic hepatitis B are not selected during lamivudine therapy[J].Journal of Medical Virology,2012.217-222.
  • 7Kobayashi S,Ide T,Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers[J].Journal of Hepatology,2001.584-586.
  • 8Xu Z,Liu Y,Xu T. Acute hepatitis B infection associated with drug-resistant hepatitis B virus[J].Journal of Clinical Virology,2010.270-274.
  • 9张继明,毛日成.HIV耐药性研究对HBV耐药性研究的借鉴[J].肝脏,2007,12(S1):40-42. 被引量:1
  • 10Kirishima T,Okanoue T,Daimon Y. Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment[J].Journal of Hepatology,2002.259-265.

二级参考文献18

共引文献4

同被引文献35

  • 1姚光弼,朱玫,王宇明,徐道振,谭德明,陈成伟,侯金林.恩替卡韦与拉米夫定治疗慢性乙型肝炎随机、双盲、双模拟对照研究[J].中华内科杂志,2006,45(11):891-895. 被引量:93
  • 2范敬华,邓敏.苦参素联合黄芪注射液对慢性乙型肝炎肝纤维化的疗效观察[J].海南医学院学报,2007,13(3):233-234. 被引量:7
  • 3Tran TT,Trinh TN,Abe K.New complex recombinant genotype of hepatitis B virus identified in Vietnam[J].J Virol,2008,82(11):5657-5663.
  • 4Olinger CM,Jutavijittum P,Hubschen JM,et al.Muller CP:Pos- sible new hepatitis B virus genotype,southeast Asia[J].Emerg In- fect Dis,2008,14(11):1777-1780.
  • 5Chu CM,Liaw YF.Genotype C hepatitis B virus infection is asso- ciated with a higher risk of reactivation of hepatitis B and progres- sion to cirrhosis than genotype B:a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline[J].J Hepatol,2005,43(3):411-417.
  • 6Liu CJ,Kao JH.Genetic variability of hepatitis B virus and re- sponse to antiviral therapy[J].Antivir Ther,2008,13(5):613-624.
  • 7Lok AS,Zoulim F,Locarnini S,et al.Antiviral drug-resistant HBV:standardization of nomenclature and assays and recommen- dations for management[J].Hepatology,2007,46(1):254-265.
  • 8Emmet B. Keeffe,Douglas T. Dieterich,Steven-Huy B. Han,Ira M. Jacobson,Paul Martin,Eugene R. Schiff,Hillel Tobias.A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2008 Update[J].Clinical Gastroenterology and Hepatology.2008(12)
  • 9周霞,王宇明.乙型肝炎病毒基因分型研究进展[J].重庆医学,2008,37(1):91-93. 被引量:10
  • 10宋健,钟慧闽,朱寿美,姚萍,杨杰.苦参素联合拉米夫定治疗乙型肝炎早期肝硬化33例[J].世界华人消化杂志,2008,16(10):1124-1127. 被引量:3

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部